An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.
Clinical trial NCT04456387 · COMPLETED
Trial details
- NCT number
- NCT04456387
- Sponsor
- Zhengzhou Gensciences Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2021-09-30
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.